The Nigerian Centre for Disease Control and UN agencies say 2,997 cases have been reported in the states of Zamfara, Katsina, Kebbi, Niger and Sokoto in northwest and north-central Nigeria since the disease surfaced in December.
A statement today says most victims are between 5 and 14.
Some 500,000 doses of vaccine have arrived in Zamfara, where the disease surfaced. But officials say 2 million doses are needed and there's a worldwide shortage for the strain, which inflames the spinal cord and brain.
Meningitis killed 1,100 people and infected more than 10,000 in Nigeria and Niger in 2015.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
70% off
Smart Essential
₹810
1 Year
₹67/Month
70% off
Super Saver
₹1,170
2 Years
₹48/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
70% off